摘要 |
<p>Disclosed are aspartic protease inhibitors represented by the following Formula: wherein R<sup>1 </sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup>, R<sup>5</sup>, R<sup>6</sup>, R<sup>7a</sup>, R<sup>7b</sup> and n are as defined herein, or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising the same and methods for treating an aspartic protease mediated disorder using the same.</p> |